IDEAYA Biosciences, Inc.

IDYA

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001676725

SEC filings (opens in a new tab)

In the last 90 days, IDEAYA Biosciences, Inc. insiders filed 0 open-market purchases and 1 sale; 285 institutions reported holding it in 13F filings for Q2 2026, worth $3.80B in total; no superinvestor holds it.

Q4 2023 vs. Q3 2023

How the institutions holding IDEAYA Biosciences, Inc. changed between Q3 2023 and Q4 2023.

All holders in Q4 2023 All holders in Q3 2023

13F holders of IDYA: Q3 2023 compared with Q4 2023
Measure	Q3 2023	Of which not filed for Q4 2023	Q4 2023	Change
Holders	144	3	157	+16
Shares	59.7M	2.71M	66.1M	+9.14M (+16.0%)
Value	$1.61B	$73.1M	$2.35B	+$815.3M (+53.0%)

3 institutions that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (30)

Institutions that held IDEAYA Biosciences, Inc. at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to IDYA in Q4 2023
Institution	Shares	Value	% of portfolio
Redmile Group, LLC	935,863	$33.3M	1.19%
Pictet Asset Management Holding SA	875,747	$31.2M	0.03%
Soleus Capital Management, L.P.	564,700	$20.1M	2.23%
Balyasny Asset Management LLC	466,271	$16.6M	0.05%
First Turn Management, LLC	382,382	$13.6M	1.95%
Victory Capital Management Inc	346,490	$12.3M	0.01%
First Light Asset Management, LLC	345,674	$12.3M	0.99%
Superstring Capital Management LP	251,295	$8.94M	6.38%
First Trust Advisors LP	120,614	$4.29M	0.00%
Nicholas Investment Partners, LP	110,351	$3.93M	0.46%
Wellington Management Group LLP	83,984	$2.99M	0.00%
Healthcare of Ontario Pension Plan Trust Fund	71,000	$2.53M	0.01%
Capstone Investment Advisors, LLC	55,239	$1.97M	0.03%
Jefferies Financial Group Inc.	17,500	$622.6K	0.01%
Virtu Financial LLC	16,369	$582.0K	0.05%
Y-Intercept (Hong Kong) Ltd	14,218	$505.9K	0.05%
Walleye Trading LLC	12,589	$447.9K	0.01%
Legato Capital Management LLC	12,494	$444.5K	0.06%
Cubist Systematic Strategies, LLC	10,611	$377.5K	0.00%
E Fund Management Co., Ltd.	10,385	$369.5K	0.02%
Martingale Asset Management L P	8,269	$294.2K	0.01%
Engineers Gate Manager LP	7,440	$264.7K	0.01%
Fox Run Management, L.L.C.	6,845	$243.5K	0.06%
Callan Capital, LLC	6,726	$239.3K	0.02%
Jump Financial, LLC	6,045	$215.1K	0.01%
Creative Planning	5,768	$205.2K	0.00%
BIT Capital GmbH	4,237	$150.8K	0.02%
AJOVista, LLC	2,778	$98.8K	0.12%
GAMMA Investing LLC	83	$3.61K	0.00%
Fortitude Family Office, LLC	5	$178	0.00%

Sold out (14)

Institutions that held IDEAYA Biosciences, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.

Institutions that sold out of IDYA in Q4 2023
Institution	Shares, Q3 2023	Value, Q3 2023
Commodore Capital LP	775,000	$20.9M
First Manhattan Co	593,065	$16.0M
Ikarian Capital, LLC	216,949	$5.85M
Boothbay Fund Management, LLC	47,543	$1.28M
Voloridge Investment Management, LLC	40,753	$1.10M
Ghisallo Capital Management LLC	37,500	$1.01M
SG Americas Securities, LLC	21,025	$567.0K
Tudor Investment Corp Et Al	20,931	$564.7K
Los Angeles Capital Management LLC	18,802	$507.3K
Norges Bank	12,800	$345.3K
Aigen Investment Management, LP	8,950	$241.5K
XTX Topco Ltd	8,159	$220.1K
Allspring Global Investments Holdings, LLC	3,599	$97.1K
Baker Avenue Asset Management, LP	54	$1.46K

Not filed for Q4 2023 yet (3)

Institutions that held IDEAYA Biosciences, Inc. at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding IDYA in Q3 2023 that haven't filed for Q4 2023
Institution	Shares, Q3 2023	Value, Q3 2023
Canaan Partners X LLC	2,660,713	$71.8M
Jacob Asset Management of New York LLC	34,103	$920.1K
Virginia Retirement Systems Et Al	15,200	$410.1K